Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis

Cancer Research

Volumn 66, Issue 17, 2006, Pages 8319-8326

  Christiansen, Jason J ^a   Rajasekaran, Ayyappan K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA5 INTEGRIN; CATENIN; CLAUDIN; CYTOKERATIN 19; CYTOKERATIN 8; DESMOPLAKIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN LINKED KINASE; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE; MUCIN 1; OCCLUDIN; PROTEIN ZO1; RAS PROTEIN; SMAD PROTEIN; STROMELYSIN 3; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN; ZINC FINGER PROTEIN;

CANCER INVASION; CANCER RESEARCH; CARCINOMA CELL; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL INVASION; CELL JUNCTION; CELL MOTILITY; E BOX ELEMENT; EPITHELIUM CELL; HUMAN; MESENCHYME CELL; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

CARCINOMA; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASES; MESODERM; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 33749024777     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0410     Document Type: Review

References (90)

1. Farquhar MG, Palade GE. Junctional complexes in various epithelia. J Cell Biol 1963;17:375-412.
2. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003;15:740-6.
3. Burdsal CA, Damsky CH, Pedersen RA. The role of E-cadherin and integrins in mesoderm differentiation and migration at the mammalian primitive streak. Development 1993;118:829-44.
4. Nieto MA. The early steps of neural crest development. Mech Dev 2001;105:27-35.
5. 2+-dependent cell adhesion molecule. BioEssays 1989;11:88-91.
6. Byers SW, Sommers CL, Hoxter B, et al. Role of E-cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: measurement of cell-cell adhesion strength. J Cell Sci 1995;108:2053-64.
7. Behrens J, Mareel MM, Van Roy FM, et al. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989;108:2435-47.
8. Le PU, Nguyen TN, Drolet-Savoie P, et al. Increased β-actin expression in an invasive Moloney sarcoma virus-transformed MDCK cell variant concentrates to the tips of multiple pseudopodia. Cancer Res 1998;58:1631-5.
9. Zheng ZH, Sun XJ, Zhou HT, et al. Analysis of metastasis suppressing function of E-cadherin in gastric cancer cells by RNAi. World J Gastroenterol 2005;11:2000-3.
10. Anderson JM, Van Itallie CM. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 1995;269:G467-75.
11. van Meer G, Simons K. The function of tight junctions in maintaining differences in lipid composition between the apical and the basolateral cell surface domains of MDCK cells. EMBO J 1986;5:1455-64.
12. Christiansen J, Rajasekaran AK. Biological impediments to monoclonal antibody-based cancer immunotherapy. Mol Cancer Ther 2004;3:1493-501.
13. Li S, Guan JL, Chien S. Biochemistry and biomechanics of cell motility. Annu Rev Biomed Eng 2005;7:105-50.
14. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 2003;194:1-11.
15. Duprey P, Paulin D. What can be learned from intermediate filament gene regulation in the mouse embryo. Int J Dev Biol 1995;39:443-57.
16. Lang SH, Hyde C, Reid IN, et al. Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. Prostate 2002;52:253-63.
17. Lagamba D, Nawshad A, Hay ED. Microarray analysis of gene expression during epithelial-mesenchymal transformation. Dev Dyn 2005;234:132-42.
18. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7:131-42.
19. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005;17:548-58.
20. Weidner KM, Arakaki N, Hartmann G, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci U S A 1991;88:7001-5.
21. Boyer B, Roche S, Denoyelle M, et al. Src and Ras are involved in separate pathways in epithelial cell scattering. EMBO J 1997;16:5904-13.
22. Liu H, Radisky DC, Bissell MJ. Proliferation and polarity in breast cancer: untying the gordian knot. Cell Cycle 2005;4:646-9.
23. Peinado H, Quintanilla M, Cano A. Transforming growth factor β-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem 2003;278:21113-23.
24. Behrens J, Vakaet L, Friis R, et al. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 1993;120:757-66.
25. Warren SL, Nelson WJ. Nonmitogenic morphoregulatory action of pp60v-src on multicellular epithelial structures. Mol Cell Biol 1987;7:1326-37.
26. Palacios F, Tushir JS, Fujita Y, et al. Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol Cell Biol 2005;25:389-402.
27. Leptin M. twist and snail as positive and negative regulators during Drosophila mesoderm development. Genes Dev 1991;5:1568-76.
28. Nieto MA, Sargent MG, Wilkinson DG, et al. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 1994;264:835-9.
29. Ohkubo T, Ozawa M. The transcription factor Snail down-regulates the tight junction components independently of E-cadherin down-regulation. J Cell Sci 2004;117:1675-85.
30. Ikenouchi J, Matsuda M, Furuse M, et al. Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 2003;116:1959-67.
31. Espineda CE, Chang JH, Twiss J, et al. Repression of Na,K-ATPase β1-subunit by the transcription factor snail in carcinoma. Mol Biol Cell 2004;15:1364-73.
32. Tripathi MK, Misra S, Chaudhuri G. Negative regulation of the expressions of cytokeratins 8 and 19 by SLUG repressor protein in human breast cells. Biochem Biophys Res Commun 2005;329:508-15.
33. Guaita S, Puig I, Franci C, et al. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 2002;277:39209-16.
34. del Barrio MG, Nieto MA. Overexpression of Snail family members highlights their ability to promote chick neural crest formation. Development 2002;129:1583-93.
35. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-p family signalling. Nature 2003;425:577-84.
36. Xie L, Law BK, Chytil AM, et al. Activation of the Erk pathway is required for TGF-β1-induced EMT in vitro. Neoplasia 2004;6:603-10.
37. Verschueren K, Remacle JE, Collart C, et al. SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5′-CACCT sequences in candidate target genes. J Biol Chem 1999;274:20489-98.
38. Comijn J, Berx G, Vermassen P, et al. The two-handed E box binding zinc finger protein SIP1 down-regulates E-cadherin and induces invasion. Mol Cell 2001;7:1267-78.
39. Tomasek JJ, McRae J, Owens GK, et al. Regulation of α-smooth muscle actin expression in granulation tissue myofibroblasts is dependent on the intronic CArG element and the transforming growth factor-β1 control element. Am J Pathol 2005;166:1343-51.
40. Xu G, Bochaton-Piallat ML, Andreutti D, et al. Regulation of α-smooth muscle actin and CRBP-1 expression by retinoic acid and TGF-β in cultured fibroblasts. J Cell Physiol 2001;187:315-25.
41. Ozdamar B, Bose R, Barrios-Rodiles M, et al. Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity. Science 2005;307:1603-9.
42. Rajasekaran SA, Palmer LG, Quan K, et al. Na,K-ATPase β-subunit is required for epithelial polarization, suppression of invasion, and cell motility. Mol Biol Cell 2001;12:279-95.
43. Begum R, Nur EKMS, Zaman MA. The role of Rho GTPases in the regulation of the rearrangement of actin cytoskeleton and cell movement. Exp Mol Med 2004;36:358-66.
44. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004;118:277-9.
45. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004;117:927-39.
46. Castanon I, Baylies MK. A Twist in fate: evolutionary comparison of Twist structure and function. Gene 2002;287:11-22.
47. Islam S, Carey TE, Wolf GT, et al. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 1996;135:1643-54.
48. Lilienbaum A, Paulin D. Activation of the human vimentin gene by the Tax human T-cell leukemia virus: I. Mechanisms of regulation by the NF-κB transcription factor. J Biol Chem 1993;268:2180-8.
49. Rubin MA, Putzi M, Mucci N, et al. Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. Clin Cancer Res 2000;6:1038-45.
50. Christiansen JJ, Rajasekaran SA, Inge L, et al. N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy. Mol Cancer Ther 2005;4:704-14.
51. Ng WK. Fine-needle aspiration cytology findings of an uncommon micropapillary variant of pure mucinous carcinoma of the breast: review of patients over an 8-year period. Cancer 2002;96:280-8.
52. Tan DS, Potts HW, Leong AC, et al. The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast. J Pathol 1999;189:20-7.
53. Langbein L, Pape UF, Grund C, et al. Tight junction-related structures in the absence of a lumen: occludin, claudins and tight junction plaque proteins in densely packed cell formations of stratified epithelia and squamous cell carcinomas. Eur J Cell Biol 2003;82:385-400.
54. Economopoulou P, Hanby A, Odell EW. Expression of E-cadherin, cellular differentiation and polarity in epithelial salivary neoplasms. Oral Oncol 2000;36:515-8.
55. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993;53:1696-701.
56. Madhavan M, Srinivas P, Abraham E, et al. Cadherins as predictive markers of nodal metastasis in breast cancer. Mod Pathol 2001;14:423-7.
57. Zhou YN, Xu CP, Han B, et al. Expression of E-cadherin and β-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002;8:987-93.
58. Mareel MM, Behrens J, Birchmeier W, et al. Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer 1991;47:922-8.
59. Kartenbeck J, Haselmann U, Gassler N. Synthesis of junctional proteins in metastasizing colon cancer cells. Eur J Cell Biol 2005;84:417-30.
60. Gabbert HE, Mueller W, Schneiders A, et al. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 1996;69:184-9.
61. Hashizume R, Koizumi H, Ihara A, et al. Expression of β-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and α-catenin. Histopathology 1996;29:139-46.
62. Lipponen P, Saarelainen E, Ji H, et al. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 1994;174:101-9.
63. Parker C, Rampaul RS, Pinder SE, et al. E-cadherin as a prognostic indicator in primary breast cancer. Br J Cancer 2001;85:1958-63.
64. Kovacs A, Dhillon J, Walker RA. Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas. Mol Pathol 2003;56:318-22.
65. Gonzalez MA, Pinder SE, Wencyk PM, et al. An immunohistochemical examination of the expression of E-cadherin, α- and β/γ- catenins, and α2-and β1-integrins in invasive breast cancer. J Pathol 1999;187:523-9.
66. Brown KA, Aakre ME, Gorska AE, et al. Induction by transforming growth factor-β1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res 2004;6:R215-31.
67. Yanagisawa K, Uchida K, Nagatake M, et al. Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers. Oncogene 2000;19:2305-11.
68. Salovaara R, Roth S, Loukola A, et al. Frequent loss of SMAD4/DPC4 protein in colorectal cancers. Gut 2002;51:56-9.
69. Han G, Lu SL, Li AG, et al. Distinct mechanisms of TGF-β1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest 2005;115:1714-23.
70. Pinkas J, Leder P. MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition. Cancer Res 2002;62:4781-90.
71. Hay ED, Zuk A. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 1995;26:678-90.
72. Kawai N, Tsuji S, Tsujii M, et al. Tumor necrosis factor α stimulates invasion of Src-activated intestinal cells. Gastroenterology 2002;122:331-9.
73. Bruewer M, Hopkins AM, Hobert ME, et al. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin. Am J Physiol Cell Physiol 2004;287:C327-35.
74. Nawshad A, Hay ED. TGFβ3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development. J Cell Biol 2003;163:1291-301.
75. Bukholm IK, Nesland JM, Borresen-Dale AL. Re-expression of E-cadherin, α-catenin and β-catenin, but not of γ-catenin, in metastatic tissue from breast cancer patients [see comments]. J Pathol 2000;190:15-9.
76. Lang SH, Sharrard RM, Stark M, et al. Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures. Br J Cancer 2001;85:590-9.
77. Lombaerts M, van Wezel T, Philippo K, et al. E-cadherin transcriptional down-regulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. BrJ Cancer 2006;94:661-71.
78. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003;3:362-74.
79. Kolega J. The movement of cell clusters in vitro: morphology and directionality. J Cell Sci 1981;49:15-32.
80. Cooper MS, D'Amico LA. A cluster of noninvoluting endocytic cells at the margin of the zebrafish blastoderm marks the site of embryonic shield formation. Dev Biol 1996;180:184-98.
81. Friedl P, Noble PB, Walton PA, et al. Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro. Cancer Res 1995;55:4557-60.
82. Nabeshima K, Inoue T, Shimao Y, et al. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor. Cancer Res 2000;60:3364-9.
83. Nabeshima K, Inoue T, Shimao Y, et al. Cohort migration of carcinoma cells: differentiated colorectal carcinoma cells move as coherent cell clusters or sheets. Histol Histopathol 1999;14:1183-97.
84. Soulie P, Carrozzino F, Pepper MS, et al. Membrane-type-1 matrix metalloproteinase confers tumorigenicity on nonmalignant epithelial cells. Oncogene 2005;24:1689-97.
85. Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005;65:5996-6000.
86. Al-Mehdi AB, Tozawa K, Fisher AB, et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000;6:100-2.
87. Green SK, Karlsson MC, Ravetch JV, et al. Disruption of cell-cell adhesion enhances antibody-dependent cellular cytotoxicity: implications for antibody-based therapeutics of cancer. Cancer Res 2002;62:6891-900.
88. Ahnen DJ, Nakane PK, Brown WR. Ultrastructural localization of carcinoembryonic antigen in normal intestine and colon cancer: abnormal distribution of CEA on the surfaces of colon cancer cells. Cancer 1982;49:2077-90.
89. Tobioka H, Isomura H, Kokai Y, et al. Polarized distribution of carcinoembryonic antigen is associated with a tight junction molecule in human colorectal adenocarcinoma. J Pathol 2002;198:207-12.
90. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003;3:921-30.